Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-22-000125

Chief Medical Officer acquired 22,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ho Carole Chief Medical Officer 2022-08-09 Grant or award +22,500 110,597 D: show line 1 in the form
Loading xslF345X03/wf-form4_166026015800698.xml…